ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01968551
Brief Title: Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults

First Submitted : September 26, 2013
First Submitted that Met QC Criteria : October 18, 2013
First Posted : October 24, 2013 (Estimate)

Results First Submitted : July 20, 2016
Results First Submitted that Met QC Criteria : September 14, 2016
Results First Posted : November 1, 2016 (Estimate)

Certification/Extension First Submitted : April 16, 2015
Certification/Extension First Submitted that Met QC Criteria : April 16, 2015
Certification/Extension First Posted : May 6, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : July 7, 2017
Last Update Posted : August 14, 2017